Faculty and fellows from the Temple Lung Center visited to San Diego to present over 55 abstracts at the American Thoracic Society International Conference, also known as ATS, from May 18-22. ATS is a chance for scientists, researchers, and healthcare professionals to come together and share the latest advancements in respiratory science, patient care, and global respiratory health.
As one of the nation’s leading lung disease research centers, and one of the most active locations for pulmonary care in the U.S.—with an exceptional lung transplant program, cutting-edge clinical trials, and innovative treatment options—the Temple Lung Center’s faculty and fellows had a considerable amount of exciting research to present at ATS.
Gerard J. Criner, MD, FACP, FACCP, Director of the Temple Lung Center and Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine, and Nathaniel Marchetti, DO, Medical Director of the Respiratory Intensive Care Unit at Temple University Hospital and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine, presented evidence for emerging therapeutic strategies in treating chronic obstructive pulmonary disease (COPD), including data from AIRFLOW-3 and ENHANCE clinical trials.
Rohit Gupta, MD, Director of the Sarcoidosis Program at Temple University Hospital and Associate Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine, had a packed room for his “Meet the Expert” session in which he discussed the evolving therapeutics landscape for managing pulmonary sarcoidosis.
Zehra Dhanani, MD, a second-year fellow in Pulmonary and Critical Care Medicine (PCCM), accepted ATS’ 2024 Innovations in Fellowship Education Award, which recognizes programs that have shown a commitment to educational excellence. Dr. Dhanani’s winning abstract, “TextBytes for Smarter Practice: Revolutionizing Tobacco Use Disorder Treatment Education for Physicians,” highlighted the use of text message-based education on tobacco use disorder management—an area identified as lacking in physician training—as an innovative learning tool well-suited for a fast-paced environment.
Third-year PCCM fellows Michaela Seigo, DO, and Stephen Dachert, MD, presented the latest research and developments coming out of the Temple Healthy Chest Initiative (THCI): Temple’s Health System-wide lung cancer screening program coupled with comorbidity detection.
The Temple Lung Center’s Key Account Management and Marketing teams also staffed a booth in the conference’s exhibit hall showcasing Temple’s most recent advancements in science, patient care, and global respiratory health, and advertising the GOLD Conference taking place later this year. The Lung Center also hosted a networking reception for faculty and alumni to celebrate the research and accomplishments presented at this year’s meeting. It was a way for us to honor our ATS participants, and to look forward to another successful year of leading-edge treatments, research, and patient care here at Temple Health.